Yüklüyor......

Effects of the MDM2 promoter SNP285 and SNP309 on Sp1 transcription factor binding and cancer risk

The proto-oncogene MDM2 inhibits p53 and plays a key role in cell growth control and apoptosis. Identification of two antagonizing MDM2 polymorphisms, SNP285 and SNP309, affecting cancer risk through modulation of Sp1 transcription factor binding, shed new light on the biological activity and phylog...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Knappskog, Stian, Lønning, Per E
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Landes Bioscience 2011
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3265776/
https://ncbi.nlm.nih.gov/pubmed/22231115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/trns.2.5.16813
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!